πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 822 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7759359

Method of treating bladder dysfunction with once-a-day trospium salt formulation

Supernus Pharmaceuticals, Inc. Β· Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7749536

Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7749532

Once daily formulations of tetracyclines

Supernus Pharmaceuticals, Inc. Β· Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7678828

Methods for the formulation and manufacture of artesunic acid for injection

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7678764

Protein formulations for use at elevated temperatures

JOHNSON & JOHNSON REGENERATIVE THERAPEUTICS, LLC Β· Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655758

Stable liquid IL-1 antagonist formulations

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7629005

Pharmaceutical formulation consisting of a plant dry extract with a calcium coating

Bionorica AG Β· Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7619117

Rasagiline formulations and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7608261

VEGF antagonist formulations suitable for intravitreal administration

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7598420

Rasagiline formulations and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582312

Methods to produce lung surfactant formulations via lyophilization and formulations and us

Discovery Laboratories, Inc. Β· Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572893

IL-1 antagonist formulations

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572834

Rasagiline formulations and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566462

Stable tablet formulation

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7462603

Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo d

The Regents of the University of California Β· Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7429562

Cyclosporin analog formulations

Isotechnika, Inc. Β· Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7396542

Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368435

Topical endoparasiticide and ectoparasiticide formulations

Summit VetPharm, LLC Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7365165

IL-1 antagonist formulations

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7357945

Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparatio

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7294687

Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Nov 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7259153

Drug formulation and delivery using crystalline methylated cyclodextrins

Supernus Pharmaceuticals, Inc. Β· Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7247707

Albumin-free factor VIII formulations

UNIVERSITY OF CONNECTICUT Β· Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7196074

Methods of making, using and pharmaceutical formulations comprising 7Ξ±, 11Ξ²-dimethyl-17Ξ²-h

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted